Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

41.00
+0.20000.49%
Volume:483.50K
Turnover:20.03M
Market Cap:1.40B
PE:-6.34
High:42.38
Open:40.38
Low:40.38
Close:40.80
52wk High:109.00
52wk Low:33.40
Shares:34.14M
Float Shares:33.55M
Volume Ratio:0.31
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4680
EPS(LYR):-9.7254
ROE:-35.75%
ROA:-12.54%
PB:1.55
PE(LYR):-4.22

Loading ...

Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 03, 2024

Correspondence

Form CORRESP - Correspondence
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 17, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]